ALK and ROS1 Double-Rearranged Lung Squamous Cell Carcinoma Responding to Crizotinib Treatment: A Case Report

J Thorac Oncol. 2017 Dec;12(12):e193-e197. doi: 10.1016/j.jtho.2017.08.021. Epub 2017 Sep 11.

¹ Graduate Shool, Southern Medical University, Guangzhou, People's Republic of China.
² Department of Respiratory Medicine, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, People's Republic of China. Electronic address: [email protected].
³ Department of Pathology, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, People's Republic of China.
⁴ Department of Respiratory Medicine, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, People's Republic of China.
⁵ Burning Rock Biotech, Guangzhou, People's Republic of China.
⁶ Department of Radiology, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, People's Republic of China.

No abstract available

Publication types